CND Life Sciences
cndlifesciences.com
Actively hiring
E-learning
Biotechnology
Health Care
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$26.4M
11 rounds on record
Latest round
$8.6M
Venture round · Feb 2025 · 19 mo ago
Grants
$9.1M
4 grants · CORDIS
The money's age
Due for its next round
19 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jun 9
Took on debt financing $6.3M · SEC Form D
Sep 5, 2025
Won a grant $1.3M · CORDIS
Feb 28, 2025
Raised a round Venture round $8.6M · SEC Form D
Feb 28, 2025
Raised a round Venture round $8.6M · SEC Form D
Mar 20, 2024
Raised a round Venture round $2M · SEC Form D
Jul 14, 2023
Took on debt financing $1.5M · SEC Form D
Sep 15, 2022
Won a grant $3M · CORDIS
Apr 1, 2022
Won a grant $2.4M · CORDIS
Oct 29, 2021
Raised a round Venture round $4.2M · SEC Form D
Jan 20, 2021
Board appointment Roy Freeman, Director · SEC Form D
Jan 5, 2021
Raised a round Venture round $2.9M · SEC Form D
Sep 30, 2020
Won a grant $2.4M · CORDIS
2017
Founded
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Debt Financing | Jun 2026 | $6.3M | — | SEC Form D |
| Grant | Sep 2025 | $1.3M | — | CORDIS |
| Venture round | Feb 2025 | $8.6M | — | SEC Form D |
| Venture round | Feb 2025 | $8.6M | — | SEC Form D |
| Venture round | Mar 2024 | $2M | — | SEC Form D |
| Debt Financing | Jul 2023 | $1.5M | — | SEC Form D |
| Grant | Sep 2022 | $3M | — | CORDIS |
| Grant | Apr 2022 | $2.4M | — | CORDIS |
| Venture round | Oct 2021 | $4.2M | — | SEC Form D |
| Venture round | Jan 2021 | $2.9M | — | SEC Form D |
| Grant | Sep 2020 | $2.4M | — | CORDIS |
Registers and programsofficial lists and records that name the company
| Legal entity | CND Life Sciences, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Richard MorelloExecutive Officer, DirectorSEC Form D
Todd LevineExecutive Officer, DirectorSEC Form D
Peter HarrisExecutive Officer, DirectorSEC Form D
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Advancing Accessible Solutions for Complex Neurodegenerative Diseases. Protecting neurons to advance treatment for neurodegenerative…
Our Mission. Deliver medicines that transform the lives of patients with neurodegenerative diseases.
Atalanta was created to address the urgent global need for interventions to treat neurodegenerative diseases.
AI-Powered Digital Infrastructure for Learning & Assessments. LMS for online programs, proctored exams, talent assessments, hiring tests…
Modulo is decoding the neuroimmune system. Applying science and engineering to identify new treatment paths for neurodegenerative diseases.
A biotech company dedicated to developing transformative medicines for people with neurodegenerative diseases using cutting-edge science…
People
Richard Morello
Executive Officer, Director
Todd Levine
Executive Officer, Director
Peter Harris
Executive Officer, Director
Jack Seaver
Director
Enrique Carrazana
Director
Christopher Gibbons
Director
Roy Freeman
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
4
Hiring now
0
Countries
1
Loading the map
Headquarters
Builds here
Office with open vacancies
No open vacancies right now Tap a pin for the office
Scottsdale
United States
HQ
Our suite of neurodiagnostic tests provides clinicians with objective pathological insights on diseases that are often d
9165 E Del Camino Dr, Suite 101, Scottsdale, AZ 85258-4381
Atlanta
United States
Regional office
Atlanta
190 Ottley Drive NE, Suite J, Atlanta, GA 30324-3925
Media
United States
Regional office
Media Inquiries
9165 E Del Camino Dr, Suite 101, Scottsdale, AZ 85258-4381
Boston
United States
Regional office
Boston
1371 Beacon Street, Suite 301, Brookline, MA 02446-4695
Financials
Total raised
$43.2M
Latest round
Debt Financing
Funding rounds
11
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Debt Financing | 2026 | $6.3M | Details |
| Grant | 2025 | $1.3M | Details |
| Venture - Series Unknown | 2025 | $8.6M | Details |
| Venture - Series Unknown | 2025 | $8.6M | Details |
| Venture - Series Unknown | 2024 | $2M | Details |
| Debt Financing | 2023 | $1.5M | Details |
| Grant | 2022 | $3M | Details |
| Grant | 2022 | $2.4M | Details |
| Venture - Series Unknown | 2021 | $4.2M | Details |
| Venture - Series Unknown | 2021 | $2.9M | Details |
| Grant | 2020 | $2.4M | Details |